Residual Right Coronary Artery Stenosis after Left Main Coronary Artery Intervention Increased the 30-Day Cardiovascular Death and 3-Year Right Coronary Artery Revascularization Rate
Table 1
Baseline characteristics and clinical status between the two groups.
Without RCA intervention N = 61 (%)
With RCA intervention N = 174 (%)
value
Age (years), mean
69.39 ± 9.68
67.10 ± 10.58
0.138
Body weight (kg), mean
63.93 ± 9.85
66.17 ± 11.55
0.178
Male
46 (75.4%)
132 (75.9%)
0.943
Diabetes mellitus
42 (68.9%)
100 (57.5%)
0.118
Hypertension
46 (75.4%)
148 (85.1%)
0.088
Current smokers
10 (16.4%)
42 (24.1%)
0.210
Hyperlipidemia
35 (57.4%)
111 (63.8%)
0.374
Chronic kidney disease
40 (65.6%)
94 (54%)
0.117
Hemodialysis
5 (8.2%)
13 (7.5%)
0.787
Previous stroke
15 (24.6%)
24 (13.8%)
0.051
Previous myocardial infarction
14 (23.0%)
27 (15.5%)
0.188
Previous coronary artery disease
25 (41.0%)
64 (36.8%)
0.560
Peripheral artery disease
8 (13.1%)
11 (6.3%)
0.094
LVEF <40%
8 (13.6%)
17 (10.2%)
0.477
Atrial fibrillation history
1 (1.6%)
8 (4.6%)
0.453
Warfarin or NOAC use
0 (0%)
2 (1.1%)
1.0
Acute NSTEMI
15 (24.6%)
56 (32.2%)
0.266
Respiratory failure
6 (9.8%)
12 (6.9%)
0.458
Ventricular arrhythmia
3 (4.9%)
4 (2.3%)
0.380
IABP
10 (16.4%)
26 (14.9%)
0.787
Temporary pacemaker
1 (1.6%)
5 (2.9%)
1.000
UGI bleeding
4 (6.6%)
6 (3.4%)
0.290
Hospital stay (mean)
13.07 ± 22.67
9.74 ± 12.63
0.280
Hospital stay (median)
6 (3–14)
6 (4–9)
0.528
Data are presented as the mean ± standard deviation, n (%), and median (IQR). Fisher’s exact test. IABP = intra-aortic balloon pump; LVEF = left ventricular ejection fraction; RCA = right coronary artery; NOAC = novel oral anticoagulants; NSTEMI = non-ST-elevation myocardial infarction; and UGI = upper gastrointestinal bleeding.
